Health and Fitness Health and Fitness
Thu, August 2, 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
Rosetta Genomics Announces Pricing of Public Offering of 5.5 Million Ordinary Shares
[ Thu, Aug 02nd 2012 ] - Market Wire
Accuray anuncia el primer Sistema CyberKnife en Sudamrica
[ Thu, Aug 02nd 2012 ] - Market Wire
MethylGene Reports Second Quarter 2012 Financial .. s and Provides an Update on its Clinical Programs
[ Thu, Aug 02nd 2012 ] - Market Wire
MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
[ Thu, Aug 02nd 2012 ] - Market Wire
Medivation Announces Second Quarter 2012 Financial Results Teleconference on August 9, 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
Watson Applauds GPhA Study Demonstrating $1 Trill .. Prescription Drug Savings from Generic Medicines
[ Thu, Aug 02nd 2012 ] - Market Wire
Nektar to Announce Financial Results for the Seco .. y, August 9, 2012, After Close of U.S.-Based Fina
[ Thu, Aug 02nd 2012 ] - Market Wire
MSA Declares Third Quarter Dividend
[ Thu, Aug 02nd 2012 ] - Market Wire
Mylan Applauds Study Highlighting $1 Trillion in .. Care System Due to Generic Drugs Over Past Decade
[ Thu, Aug 02nd 2012 ] - Market Wire
USANA Recognized For The Fourth Consecutive Year .. erica's 'Best Places to Work' By Outside Magazine
[ Thu, Aug 02nd 2012 ] - Market Wire
Acura Pharmaceuticals Supports the Stop Tampering of Prescription Pills Act of 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
Mylan Signs Agreement with Gilead to Accelerate A .. ixed-Dose Combination ARVs Containing Emtricitabi
[ Thu, Aug 02nd 2012 ] - Market Wire
Waters and Nonlinear Dynamics to Co-Develop Next .. arch Solutions for Large-Scale, Complex Data Sets
[ Thu, Aug 02nd 2012 ] - Market Wire
Alliqua Names Stephen A. Brigido, D.P.M. Chairman of Scientific Advisory Board
[ Thu, Aug 02nd 2012 ] - Market Wire
Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
[ Thu, Aug 02nd 2012 ] - Market Wire
Accuray Announces First CyberKnife System in South America
[ Thu, Aug 02nd 2012 ] - Market Wire
ZYTO Corp Announces Expansion of Scientific Advisory Board
[ Thu, Aug 02nd 2012 ] - Market Wire
Paladin Reports Second Quarter 2012 Results-Increases 2012 Revenue Guidance to Over $200 Million
[ Thu, Aug 02nd 2012 ] - Market Wire
Bioheart Receives $ 2 Million Term Sheet Investme .. bal Leader in Healthcare in Latin America and Eur
[ Thu, Aug 02nd 2012 ] - Market Wire
Implant Sciences Awarded Follow-On Order to China for Aviation Security
[ Thu, Aug 02nd 2012 ] - Market Wire
Comprehensive Care Corporation Names Colonel Ramo .. Advisor To Maximize its Market Share with New Pha
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ] - Market Wire
Haemonetics Completes Acquisition of Pall's Transfusion Medicine Business
[ Wed, Aug 01st 2012 ] - Market Wire
Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
[ Wed, Aug 01st 2012 ] - Market Wire
NuVasive to Participate in the Canaccord Genuity Growth Conference
[ Wed, Aug 01st 2012 ] - Market Wire
Alexza Announces Management Promotions
[ Wed, Aug 01st 2012 ] - Market Wire
Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
[ Wed, Aug 01st 2012 ] - Market Wire
Sarepta Therapeutics to Present Company Overview .. e 32nd Canaccord Genuity Annual Growth Conference
[ Wed, Aug 01st 2012 ] - Market Wire
Masimo Enters Noninvasive Multigas Monitoring, including Capnography, with Acquisition of PHASEIN
[ Wed, Aug 01st 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation to Report Seco .. ts and Host a Conference Call to Update Investors
[ Wed, Aug 01st 2012 ] - Market Wire
Anthera to Report Second Quarter 2012 Financial Results

Anthera to Report Second Quarter 2012 Financial Results


Published on 2012-08-01 12:30:47 - Market Wire
  Print publication without navigation


Anthera to Report Second Quarter 2012 Financial Results -- HAYWARD, Calif., Aug. 1, 2012 /PRNewswire/ --

Anthera to Report Second Quarter 2012 Financial Results

[ ]

HAYWARD, Calif., Aug. 1, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: [ ANTH ]), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced it will report its unaudited financial results for the second quarter ended June 30, 2012 on Tuesday, August 7, 2012, after the market closes in the United States.

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases.

SOURCE Anthera Pharmaceuticals, Inc.



[ Back to top ]

RELATED LINKS
[ http://www.anthera.com ]

Contributing Sources